WASHINGTON — By now we've all heard that the Pfizer COVID-19 vaccine has an efficacy rate of 95%, Moderna of 94%, and Johnson & Johnson about 66%; what you may not have known is that rate's technical ...
IN THIS issue of the Journal of Clinical Oncology, Chao et al 1 report the results of a study that examined the impact of using four different risk/benefit measures when communicating survival ...
Researchers provided comprehensive evidence of the benefits of statin use in elderly patients, addressing longstanding uncertainties. The robust evidence demonstrated that continuous statin therapy ...
Nearly 7 million patients present to U.S. emergency departments annually for evaluation of possible acute coronary syndromes (ACSs). Despite hospital admission of the 25% to 30% who have atypical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback